Category: Gene Therapy
Global Gene Therapy
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Exosome Type (Natural, Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region and Competition, 2019-2029F
... (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region and Competition, 2019-2029F Global Exosome Therapeutics Market was valued at USD 31.63 Million in 2023 ... Read More
-
Biological Safety Testing Market – By Product and Services (Consumables, Instruments, Services, Reagents & Kits), Application (Gene Therapy, Stem Cells), Test Type (Endotoxin Test, Sterility Test, Bioburden Tests) – Global Forecast (2024 – 2032)
... safety testing market size is set to register 13.6% CAGR during 2024-2032, driven by the rising regulatory scrutiny and stringent safety standards imposed by health authorities worldwide. Regulatory agencies, such as the FDA, EMA, and ... Read More
-
2024 Global Cell And Gene Therapy Clinical Trials Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Cancer Gene Therapy Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
2024 Global Cell And Gene Therapy Manufacturing Services Market Industry (2030 Outlook)
... 46 countries (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 ... Read More
-
Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2024
... a CAGR of 8.91% during 2024-2030. North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 432.24 million in 2023 to reach $ 653 million by 2030, at a CAGR ... Read More
-
Global Cell and Gene Therapy Market
... type, product, application, and region. BCC determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next five years. The report provides a detailed analysis ... Read More
-
2024 Global: Cancer Gene Therapy Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Product (Consumables and Equipment), Application (Biopharmaceutical Production, Cell & Gene Therapy, Tissue Engineering, and Others), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and Region
... microcarrier is a small particle, typically ranging in size from 0.1 to 10 micrometers, that can be used to culture cells in suspension. Microcarriers are usually made of polystyrene, glass, or other biocompatible materials, and ... Read More
-
2024 Global: Cell And Gene Therapy Clinical Trials - Innovative Markets Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Biological Safety Testing Market Size, Trends, Analysis, and Outlook By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, 2024-2030
... Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, ... Read More
-
Cancer Biologics Market Size, Trends, Analysis, and Outlook By Product (Monoclonal antibodies, Cell and gene therapy, Vaccines, Others), By Route of Administration (Injectable, Oral), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 9.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Biologics market By Product (Monoclonal ... Read More
-
Cell and Gene Therapy Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Gene Type, Gene silencing, Cell replacement, Gene augmentation, Others), By Cell Type (T-Cells, Stem Cells, Other), By Application (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy market size is poised to register 20.38% growth (CAGR) from 2024 to 2030, presenting significant growth ... Read More
-
Primary Immunodeficiency Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others), By Product (Immunoglobulin Replacement Therapy, Stem Cell/Bone Marrow Transplantation, Antibiotic Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Primary Immunodeficiency Therapeutics market size is poised to register 7.55% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Solid Tumors Drugs Market Size, Trends, Analysis, and Outlook By Type (Small Molecules, Biologics (Enzymes, Blood and Blood Components, Gene Therapy, Recombinant Proteins, Somatic Cells, Tissues, Vaccines)), By Application (Oncology, Radiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Solid Tumors Drugs market size is poised to register 15.96% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030 The global Biologic Therapeutics market size is poised to register 7.8% growth (CAGR) from 2024 ... Read More
-
Gene Therapy for Inherited Genetic Disorders Market Size, Trends, Analysis, and Outlook By Type (Eye Disorders, Hematological Disorders, Central Nervous System Disorders, Muscular Disorders, Others), By Application (Hospital, Clinic, Research Institute, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for Inherited Genetic Disorders market size is poised to register 7.62% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Hemophilia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Hemophilia Therapeutics market size is poised to register 7.38% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Global Gene Therapy for Inherited Genetic Disorders Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Gene Therapy for Inherited Genetic Disorders is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The gene therapy market size is expected to grow from ... Read More
-
Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User - Global Forecast to 2031
... Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User—Global Forecast to 2031 The global regenerative medicine market is projected to reach $37.27 ... Read More
-
Global Thalassemia Gene Test Kit Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Thalassemia Gene Test Kit is a diagnostic tool used to detect ... Read More
-
Global Rare Disease Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Rare Disease Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
Research Assistance
